Lymphoblastic Leukemia, Acute, Childhood Recruiting Phase 2 Trials for Allopurinol (DB00437)

IndicationStatusPhase
DBCOND0044925 (Lymphoblastic Leukemia, Acute, Childhood)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03022747Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using AllopurinolTreatment